U.S. Markets closed

Stereotaxis, Inc. (STXS)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.581+0.05 (+9.62%)
At close: 3:53PM EDT
People also watch
HNSNSPNCNUROSTAAROSG
  • What caused the sudden drop shortly before trading closed ?
  • hey, i am considering buying some shares of STXS - looks like the guys from Dafna Capital took over... they are professional investors. any thoughts?
  • Any discussion on the latest earning call. Sounds like they want to do well and that they believe they have the right product. The call was great until questions were asked and then my optimism was drowned by lousy answers to simple, basic questions. What a shame.
  • BIG DEAL TO ACQUIRE UP TO 9 MARKETED PRODUCTS IMMINENT = 2000%++ UPSIDE POTENTIAL !!!
    AQSZF (MC $11 M) is close to profitability and to file 3 NDA and the whole company is valued at ridiculous $11 Million ,this unknown stock is definitely one of the cheapest Biotech in the sector .Stock should be at minimum $2+ right now .

    Market Cap :US$ 11 Million
    Cash $4.1 Million << enough untill mid 2018
    Price 0.18

    MUST WATCH to realize the MONSTER POTENTIAL HERE
    https://www.youtube.com/watch?v=jV00WmYBtv4

    Presentation
    http://www.aequuspharma.ca/Investors/AQS%20investor%20November%202016_web.pdf

    Operational profitability estimated in 2017

    File for CDN approval of Topiramate XR in 1H 2017

    File for CDN approval of Oxcarbazepine XR in 1H 2017

    Additional Product Deals in 2017

    Partnership for AQS1301 in 2017

    Two products launches to date (Tacrolimus IR and Vistitan™)

    3 long-acting, transdermal programs in development, on track to file NDA in 2018

    Aequus Pharmaceuticals
    Aequus has an expanding product pipeline of drugs in Canada. Revenues and cash flows are increasing and products produce a 50% margin, Edward Karr, Managing ...
    www.youtube.com
  • Just listened to call. Did they say they have 25 sales reps worldwide and have visibility on ONE new system sale for all of 2017? Should it be me or someone else who calls them and lets them know they don't need a sales force? They need farmers and account managers to only act on current sites.
  • Interesting momentum out there on renal denervations. Looking through the ongoing work (Symplicity Spyral, RADIANCE-HTN (NCT02649426) and REINFORCE (NCT02392351, n=100)) lots of new interest out there. What is encouraging is that back in 2011 Petr Neuzil, MD, PhD, Head of Cardiology and Director of the Cardiac Arrhythmia Service at the Na Homolce Hospital in Prague, Czech Republic used a Niobe to get this done and had 100% accuracy of ablations whereas the struggle even with say symplicity is that you have to "hope and pray" you are in the right area.
  • Double down on VT where they know <5% of all cases really need it. When are they going to start using this machine in other areas and actually think about growing their sweet spot? Cardio alone isn't going to cut it.
  • sick management these people only want pay check and bonus that all not really worried about the company and share holder fxxk that CEO
  • I also received an alert for $STXS from http://monstastocks.com/?s=STXS , any ideas? Sherman's rule of press conferences: the explanation of a disaster will be made by a stand-in. Making money day trading.

    Monsta Stocks: Trading Stocks and Making Money
    Stock alerts from the Monsta Stocks. Stock trading, making money and always looking for the next big money maker.
    monstastocks.com
  • but nobody wants to help Mom to do the dishes. http://dataunion.tistory.com/3342

    Stereotaxis Inc NASDAQ : STXS Correlation Histogram
    X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks May-2016 1,000 Day Parameter 2,830 NASDAQ Stocks Price Analysis This stock mode of correlation coefficient is -0.1 In other words, the correlation coefficient of the other stoc
    dataunion.tistory.com
  • NEXT BUYOUT TARGET HERE
    AQSZF (MC $15 M) is close to profitability and to file 3 NDA and the whole company is valued at ridiculous $15 Million ,this unknown stock is definitely one of the cheapest Biotech in the sector .Stock should be at minimum $2+ right now .

    Market Cap :US$ 15 Million
    Cash $4.1 Million << enough untill mid 2018
    Price 0.21

    MUST WATCH to realize the MONSTER POTENTIAL HERE
    https://www.youtube.com/watch?v=jV00WmYBtv4

    Presentation
    http://www.aequuspharma.ca/Investors/AQS%20investor%20November%202016_web.pdf

    AQS1301 topline results in 1Q 2017

    Operational profitability estimated in 2017

    File for CDN approval of Topiramate XR in 1H 2017

    File for CDN approval of Oxcarbazepine XR in 1H 2017

    Additional Product Deals in 2017

    Partnership for AQS1301 in 2017

    Two products launches to date (Tacrolimus IR and Vistitan™)

    3 long-acting, transdermal programs in development, on track to file NDA in 2018

  • 1,500 share volume? Even for a thinly traded stock like this, it's unusual.
  • How about endovascular repair / stent graph routing and placement via Niobe. Take a look at Lombard and their system and then connect the dots.
  • This is where I find the top NASDAQ & NYSE Trade Ideas ---> www.T0pm@rketgainers.c0m

  • “Re-engaging with capital markets is one of several key initiatives we are pursuing following my recent appointment as CEO,” said David Fischel. “I am delighted that the ROTH Conference is our first opportunity to do so.”
  • ROTH Conference

    Possibly shopping the company. I have been accumulating shares on the assumption that may be in the works, I'd imagine a possible sale price of $1 north of current SP.
  • Right... Mills and Middletons perversions (set the table) for a low ball offer if any.
    Both became very weath via Stxs, ..so is Middleton contribution since he still BOD.
    Where as Stxs has been delisted also increased shares (dilution) so why on BOD!
  • When will the Masimo influence have some effect on share price.
  • No one interested in buying this company?
  • I remember reading post from older yahoo boards speculating that Stereotaxis Market Cap was purposely being manipulated where by creating a scenario for White/Black Knight gaining control of the company, In this case DAFNA.
    Interesting